|
PF-33743 |
SCHERIPROCT Pomada |
2014-08-26 |
|
Bayer S.A., Argentina |
Argentina
|
Bayer, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39417 |
KEPPRA 100 mg/mL Solución Oral |
2026-09-27 |
|
GlaxosmithKline Trading Services Ltd. |
Francia
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28778 |
ATARAX 10 mg/5 mL Jarabe |
2022-06-26 |
|
GlaxosmithKline Trading Services Ltd. |
Francia
|
J.I.Cohen, S.A. |
Amicelco |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22254 |
BLENOXANE 15 UI Polvo para Uso Parenteral |
2009-10-13 |
|
Bristol-Myers Squibb Company |
Japón
|
Bristol Myers Squibb De Guatemala Ltda. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-8767 |
METHYCOBAL 500 mcg Solución Inyectable |
2029-03-25 |
|
Eisai Co. Ltda. |
Japón
|
Lancasco S.A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55508 |
IRESSA 250 mg Comprimidos recubiertos |
2023-07-19 |
|
Astrazeneca AB |
Japón
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59977 |
SWAPERA-TZ 4.5 g Polvo para uso parenteral |
2026-09-02 |
|
Swasthya Healthcare |
India
|
Bikasa |
Arael de Centro América |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60402 |
ERAZIN 4.5, 4.5 g Polvo para uso parenteral |
2026-12-01 |
|
Iora Lifecare Pvt Ltd |
India
|
Schindler |
Cisa |
Bikasa |
Wensur |
Droguería Colón |
LCJ |
Corfasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60483 |
NEXTONE 1000, 1000 mg Polvo para uso parenteral |
2026-12-21 |
|
Iora Lifecare Pvt Ltd |
India
|
Schindler |
Bikasa |
Wensur |
Arael de Centro América |
Droguería Colón |
LCJ |
ERETZ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57332 |
IMATINIB Masters 400 mg Cápsulas |
2024-10-15 |
|
Masters Pharmaceuticals Limited |
Polonia
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|